Legal Representation
Attorney
Jamie E. Sternberg
USPTO Deadlines
Next Deadline
1093 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-08-02)
Due Date
August 02, 2028
Grace Period Ends
February 02, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 2, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 2, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 25, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 24, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jun 23, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jun 15, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jun 15, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 11, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 10, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Feb 7, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Feb 7, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 28, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 26, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 26, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 26, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 23, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 21, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 21, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 21, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 4, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 31, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 31, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 31, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 12, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 11, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 10, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 5, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 5, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 4, 2020 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Aug 6, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 11, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 11, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 22, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 3, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 2, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 2, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 29, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 23, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 5, 2018 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Nov 5, 2018 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Nov 5, 2018 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Oct 31, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 16, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 16, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and medical preparations for the prevention and treatment of major diseases, namely, diabetes, cancer, Alzheimer's disease, atherosclerosis; peptide based medical therapeutic preparations for the prevention and treatment of major diseases, namely, diabetes, cancer, Alzheimer's disease, atherosclerosis; Pharmaceutical and medical preparations for the prevention and treatment of major diseases, namely, obesity, liver disease and fatty liver disease; peptide based medical therapeutic preparations for the prevention and treatment of major diseases, namely, obesity, fatty liver disease and liver disease
First Use Anywhere:
Jun 7, 2022
First Use in Commerce:
Jun 7, 2022
Classification
International Classes
005